References
- Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004.
- Diumenjo MC, Abriata G, Forman D, Sierra MS. The burden of non-Hodgkin lymphoma in Central and South America. Cancer Epidemiol [Internet]. 2016;44:S168–S77. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1877782116300637
- Gutiérrez MI, Bhatia K, Barriga F, Diez B, Muriel FS, de Andreas ML, et al. Molecular epidemiology of Burkitt’s lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood [Internet]. 1992;79(12):3261–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1317726
- Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, et al. Results of treatment of advanced-stage Burkitt’s lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol [Internet]. 1986;4(12):1732–9. Available from: http://ascopubs.org/doi/10.1200/JCO.1986.4.12.1732
- Patte C, Philip T, Rodary C, Zucker JM, Behrendt H, Gentet JC, et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol [Internet]. 1991;9(1):123–32. Available from: http://ascopubs.org/doi/10.1200/JCO.1991.9.1.123
- Bowman WP, Shuster JJ, Cook B, Griffin T, Behm F, Pullen J, et al. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. J Clin Oncol [Internet]. 1996;14(4):1252–61. Available from: http://ascopubs.org/doi/10.1200/JCO.1996.14.4.1252
- Diviné M, Casassus P, Koscielny S, Bosq J, Sebban C, Le Maignan C, et al. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Ann Oncol [Internet]. 2005;16(12):1928–35. Available from: http://academic.oup.com/annonc/article/16/12/1928/225760/Burkitt-lymphoma-in-adults-a-prospective-study-of
- Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol [Internet]. 1996;14(3):925–34. Available from: http://ascopubs.org/doi/10.1200/JCO.1996.14.3.925
- Patte C, Michon J, Frappaz D, Leverger G, Rubie H, Soussain C, et al. Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillieres Clin Haematol [Internet]. 1994;7(2):339–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7803905
- Wang S, He G. 2016 revision to the WHO classification of acute lymphoblastic leukemia. J Transl Int Med. 2016;4(4):147–9.
- Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin’s Lymphomas. J Clin Oncol [Internet]. 1999;17(4):1244. Available from: http://ascopubs.org/doi/10.1200/JCO.1999.17.4.1244
- Casulo C, Friedberg J. Treating Burkitt lymphoma in adults. Curr Hematol Malig Rep [Internet]. 2015;10(3):266–71. Available from: http://link.springer.com/10.1007/s11899-015-0263-4
- Soussain C, Patte C, Ostronoff M, Delmer A, Rigal-Huguet F, Cambier N, et al. Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood [Internet]. 1995;85(3):664–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7833470
- Ribrag V, Koscielny S, Bosq J, Leguay T, Casasnovas O, Fornecker L-M, et al. Rituximab and dose-dense chemotherapy for adults with Burkitt’s lymphoma: a randomised, controlled, open-label, phase 3 trial. Lancet [Internet]. 2016;387(10036):2402–11. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673615013173
- Choi MK, Jun HJ, Lee SY, Kim KH, Lim DH, Kim K, et al. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Ann Hematol [Internet]. 2009;88(11):1099–106. Available from: http://link.springer.com/10.1007/s00277-009-0729-3
- Thomas DA, Faderl S, O’Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer [Internet]. 2006;106(7):1569–80. Available from: http://doi.wiley.com/10.1002/cncr.21776
- Mead GM, Barrans SL, Qian W, Walewski J, Radford JA, Wolf M, et al. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood [Internet]. 2008;112(6):2248–60. Available from: http://www.bloodjournal.org/cgi/doi/10.1182/blood-2008-03-145128
- Rizzieri DA, Johnson JL, Byrd JC, Lozanski G, Blum KA, Powell BL, et al. Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002. Br J Haematol [Internet]. 2014;165(1):102–11. Available from: http://doi.wiley.com/10.1111/bjh.12736
- Rizzieri DA, Johnson JL, Niedzwiecki D, Lee EJ, Vardiman JW, Powell BL, et al. Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma. Cancer [Internet]. 2004;100(7):1438–48. Available from: http://doi.wiley.com/10.1002/cncr.20143
- Oosten LEM, Chamuleau MED, Thielen FW, de Wreede LC, Siemes C, Doorduijn JK, et al. Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens. Ann Hematol [Internet]. 2018;97(2):255–66. Available from: http://link.springer.com/10.1007/s00277-017-3167-7
- Hoelzer D, Walewski J, Dohner H, Viardot A, Hiddemann W, Spiekermann K, et al. Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood [Internet]. 2014;124(26):3870–9. Available from: http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-03-563627